Untitled Page

Astellas Pharma Support for the Division of Urology

Sender Herschorn shakes hands with Michael Tremblay
Left: Dr. Sender Herschorn receives a cheque from Mr. Michael Tremblay, President of Astellas Canada Pharma Inc.

The Division of Urology recently celebrated a generous gift of $300,000 from Astellas Pharma Canada Inc. in support of a research fellowship in Functional Urology. This involves the study of developmental and acquired disorders and reconstruction of the urinary tract. The tremendous support received from industry partners like Astellas, ensures that U of T leads the way in cultivating and producing the next generation of surgeons and world class researchers. Division and Martin Barkin Chair in Urological Research Dr. Sender Herschorn and Astellas President Michael Tremblay say they look forward to continued cooperation in urological research and other fields. Headquartered in Markham, Ontario, Astellas is recognized as the first Japanese pharmaceutical company in Canada. Involved in clinical research and development as well as the sales and marketing of products, Astellas focuses on key therapeutic areas such as immunology, infectious disease, cardiology, urology and dermatology.

Artur Cane with notes from Sender Herschorn

Skip Navigation Links